KEGG   DRUG: Foslevodopa and foscarbidopa
Entry
D12494            Mixture   Drug                                   
Name
Foslevodopa and foscarbidopa;
Vyalev (TN)
Product
VYALEV (AbbVie)
Component
Foslevodopa [DR:D11839], (Foscarbidopa hydarate [DR:D11879] | Foscarbidopa [DR:D12057])
Class
Metabolizing enzyme substrate
 DG01592  COMT substrate
Unclassified
 DG03250  DDC substrate
Remark
Therapeutic category: 1169
ATC code: N04BA07
Product: D12494<JP/US>
Efficacy
Antiparkinsonian
Metabolism
Enzyme: COMT [HSA:1312], DDC [HSA:1644]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N04 ANTI-PARKINSON DRUGS
   N04B DOPAMINERGIC AGENTS
    N04BA Dopa and dopa derivatives
     N04BA07 Foslevodopa and decarboxylase inhibitor
      D12494  Foslevodopa and foscarbidopa <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   116  Antiparkinsonian agents
    1169  Others
     D12494  Foslevodopa and foscarbidopa
Drug groups [BR:br08330]
 Metabolizing enzyme substrate
  DG01592  COMT substrate
   D12494  Foslevodopa and foscarbidopa
 Unclassified
  DG03250  DDC substrate
   D12494  Foslevodopa and foscarbidopa
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D12494
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D12494
Other DBs
PubChem: 497620907
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system